Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • TROP2

Tag: TROP2

Merck sac-TMT trial infographic: TroFuse-015 overall survival win in gastroesophageal cancer
  • Pharmaceuticals

Merck sac-TMT Trial Wins on Survival in Late-Line Gastroesophageal Cancer, Misses on PFS

Megan Wood4 hours ago09 mins

TroFuse-015 met its overall survival goal for Merck and Kelun’s TROP2 ADC sac-TMT in 473 pretreated gastroesophageal cancer patients, but missed progression-free survival.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (367)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (113)
  • Uncategorized (1)

Recent Posts

  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
  • AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast
  • UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts
  • Merck sac-TMT Trial Wins on Survival in Late-Line Gastroesophageal Cancer, Misses on PFS
  • Merck Isomorphic Labs Collaboration: AI Design Deal Targets One Undisclosed Cancer Target
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.